Corbus Pharmaceuticals Holdings, Inc.
CRBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595097
In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 65 | 2 | 63 | 0 |
| Shares | 23.4M | 36.0K | 11.9M | −11.5M (−49.1%) |
| Value | $3.86M | $6.38K | $1.31M | −$2.54M (−65.9%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 84,518 | $9.34K | 0.00% |
| Envestnet Asset Management Inc | 34,000 | $3.76K | 0.00% |
| National Asset Management, Inc. | 21,400 | $2.37K | 0.00% |
| HBK Sorce Advisory LLC | 13,750 | $2.00K | 0.00% |
| StoneX Group Inc. | 13,106 | $1.45K | 0.00% |
| Citadel Advisors LLC | 6,897 | $762 | 0.00% |
| CoreCap Advisors, LLC | 750 | $83 | 0.00% |
| Comerica Securities,inc. | 600 | $66 | 0.00% |
| Parallel Advisors, LLC | 200 | $22 | 0.00% |
| Sandy Spring Bank | 50 | $6 | 0.00% |
| GWM Advisors LLC | 250 | $0 | 0.00% |
Sold out (11)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $833.0K |
| ETF Managers Group, LLC | 4,710,319 | $777.0K |
| Mirae Asset Global Investments Co., Ltd. | 398,945 | $66.0K |
| Stifel Financial Corp | 107,299 | $18.0K |
| Goldman Sachs Group Inc | 88,583 | $15.0K |
| Verition Fund Management LLC | 66,053 | $11.0K |
| Two Sigma Advisers, LP | 16,800 | $3.00K |
| Millennium Management LLC | 11,585 | $2.00K |
| Toronto Dominion Bank | 4,283 | $1.00K |
| Northwestern Mutual Wealth Management Co | 2 | $0 |
| Hall Laurie J Trustee | 740 | $0 |
Not filed for Q4 2022 yet (2)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Kingsbury Capital Investment Advisors LLC | 33,700 | $6.00K |
| American Portfolios Advisors | 2,312 | $381 |